Exact Mass: 690.1162

Exact Mass Matches: 690.1162

Found 15 metabolites which its exact mass value is equals to given mass value 690.1162, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

cdiGMP

9,9-[(2r,3r,3as,5s,7ar,9r,10r,10as,12s,14ar)-3,5,10,12-Tetrahydroxy-5,12-Dioxidooctahydro-2h,7h-Difuro[3,2-D:3,2-J][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-Diyl]bis(2-Amino-1,9-Dihydro-6h-Purin-6-One)

C20H24N10O14P2 (690.0949)


   

Bis(3',5')-cyclic diguanylic acid

8,17-bis(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.3.0.0^{6,10}]octadecane-3,12-dione

C20H24N10O14P2 (690.0949)


   

Ceftobiprole medocaril

7-{[1-hydroxy-2-(hydroxyimino)-2-(5-imino-4,5-dihydro-1,2,4-thiadiazol-3-yl)ethylidene]amino}-3-[(1-{[(5-methyl-2-oxo-2H-1,3-dioxol-4-yl)methoxy]carbonyl}-2-oxo-[1,3-bipyrrolidine]-3-ylidene)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

C26H26N8O11S2 (690.1162)


   

Malvidin 3,5-diglucoside

7-hydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-3,5-bis({[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})-1λ⁴-chromen-1-ylium chloride

C29H35ClO17 (690.1563)


Malvidin 3,5-diglucoside, also known as malvin, is a member of the class of compounds known as anthocyanidin-5-o-glycosides. Anthocyanidin-5-o-glycosides are phenolic compounds containing one anthocyanidin moiety which is O-glycosidically linked to a carbohydrate moiety at the C5-position. Malvidin 3,5-diglucoside is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Malvidin 3,5-diglucoside can be found in bilberry, carrot, common bean, and wild carrot, which makes malvidin 3,5-diglucoside a potential biomarker for the consumption of these food products. Malvin reacts in the presence of H2O2 to form malvone. The ortho-benzoyloxyphenylacetic acid esters reaction product is dependant of the pH: it is obtained under acidic conditions whereas under neutral conditions, the reaction product is the 3-O-acyl-glucosyl-5-O-glucosyl-7-hydroxy coumarin .

   

Kaempferol 3-(6-sulfatogetiobioside)

Kaempferol 3-(6-sulfatogetiobioside)

C27H30O19S (690.1102)


   
   

PtdIns-(4,5)-P2 (1,2-dihexanoyl)

1-(1,2-dihexanoylphosphatidyl)inositol-4,5-bisphosphate, trisodium salt

C21H41O19P3 (690.1455)


   

PtdIns-(3,5)-P2 (1,2-dihexanoyl) (sodium salt)

1-(1,2R-dihexanoylphosphatidyl)inositol-3,5-bisphosphate, trisodium salt

C21H41O19P3 (690.1455)


   

PtdIns-(3,4)-P2 (1,2-dihexanoyl)

1-(1,2-dihexanoylphosphatidyl)inositol-3,4-bisphosphate, trisodium salt

C21H41O19P3 (690.1455)


   

Kaempferol 3-(6-sulfatogentiobioside)

Kaempferol 3-(6-sulfatogentiobioside)

C27H30O19S (690.1102)


   

Ceftobiprole medocaril free acid

Ceftobiprole medocaril free acid

C26H26N8O11S2 (690.1162)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use

   

9,9-[(2r,3r,3as,5s,7ar,9r,10r,10as,12s,14ar)-3,5,10,12-Tetrahydroxy-5,12-Dioxidooctahydro-2h,7h-Difuro[3,2-D:3,2-J][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-Diyl]bis(2-Amino-1,9-Dihydro-6h-Purin-6-One)

9,9-[(2r,3r,3as,5s,7ar,9r,10r,10as,12s,14ar)-3,5,10,12-Tetrahydroxy-5,12-Dioxidooctahydro-2h,7h-Difuro[3,2-D:3,2-J][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-Diyl]bis(2-Amino-1,9-Dihydro-6h-Purin-6-One)

C20H24N10O14P2 (690.0949)


   

7-[[(2E)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-hydroxyiminoacetyl]amino]-3-[(E)-[1-[1-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methoxycarbonyl]pyrrolidin-3-yl]-2-oxopyrrolidin-3-ylidene]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

7-[[(2E)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-hydroxyiminoacetyl]amino]-3-[(E)-[1-[1-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methoxycarbonyl]pyrrolidin-3-yl]-2-oxopyrrolidin-3-ylidene]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C26H26N8O11S2 (690.1162)


   

N(2)-(ADP-D-ribosyl)-guanine

N(2)-(ADP-D-ribosyl)-guanine

C20H24N10O14P2-2 (690.0949)


   

[6-[2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-oxo-8-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-6-yl]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl] hydrogen sulate

[6-[2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-oxo-8-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-6-yl]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl] hydrogen sulate

C27H30O19S (690.1102)